The forecasted data for breast cancer screening in Norway, focusing on women aged 50-69, shows a stable trend from 2025 to 2028, all maintaining a value of 70%. The only variation appears in 2024, where the value slightly increases to 70.1%. This stability indicates a plateau in the screening rates within the projected years, suggesting effective saturation or a reached limit in current screening strategies. Given the lack of year-on-year variation post-2024, the calculated compound annual growth rate (CAGR) over the five-year period would be minimal, reflecting the program’s maturity and possibly maximum outreach capacity under current policies and healthcare infrastructure.
Looking forward, it’s crucial to monitor changes in technology, healthcare policies, and patient engagement strategies. Innovations in screening methods, increased awareness campaigns, and policy shifts aiming to broaden eligibility could influence future trends. Additionally, the impact of global health crises on screening rates should be observed, as they may offer insights into resilience and adaptability of the screening program in Norway.